adelmidrol
Small moleculeexperimental
Adelmidrol is an anti-inflammatory ethanolamide derivative of azelaic acid. — Wikipedia
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Sep 1, 2011 (NCT01420510)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetAntioxidant
Antioxidant
Chemistry & pharmacology
Loading structure…
SMILES
O=C(CCCCCCCC(=O)NCCO)NCCO- Mol. weight
- 274.36 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaAdelmidrol ↗
- ChEMBLCHEMBL2105967 ↗
Also known as
- adelmidrol
- adelmidrol
- adelmidrol
- adelmidrol
- n,n'-bis(2-hydroxyethyl)nonanediamide
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01420510 | Phase 2/Phase 3 (Phase 3) | Sep 1, 2011 | University of Insubria |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Insubria | Academic/Hospital | 1 | 1 | 1 | 2011 |
1 organizations
Page 1 / 1